Pediatric Allergy Epidemiology explores how allergic diseases are distributed across populations, how incidence and prevalence are changing over time, and which risk and protective factors shape these patterns. As rates of food allergy, asthma, eczema, and allergic rhinitis rise in many regions, understanding population-level trends is critical for prevention, service planning, and policy. This session introduces core epidemiologic concepts applied to allergy, using real-world data to illustrate how environment, genetics, early-life exposures, and social determinants interact to influence allergic disease. Researchers and clinicians frequently look for a focused Pediatrics Conference to translate complex data into practical strategies for clinics, schools, and public-health systems.

A major theme is how birth-cohort studies, registries, surveillance systems, and electronic health records reveal trajectories of sensitisation, symptom onset, and remission. Participants will examine how urbanisation, pollution, microbiome shifts, diet, infections, and climate factors may contribute to regional differences in allergy burden. The session will also review methodological challenges such as diagnostic variability, under-reporting, selection bias, and confounders that can complicate interpretation of allergy data.

The session highlights how robust data can inform targeted pediatric allergy prevention strategies. Case examples will explore how epidemiologic findings shape guidance on early introduction of allergenic foods, breastfeeding promotion, environmental control measures, vaccination policies, and school-based programmes. Participants will consider how to identify high-risk groups, design screening or monitoring programmes, and allocate resources such as allergy clinics, dietetic support, and anaphylaxis education efficiently.

Participants will also explore the role of digital tools and big-data approaches, including linkage of health, environmental, and socio-demographic datasets to uncover subtle patterns and emerging risks. Discussion will include the ethical implications of predictive analytics, risk stratification tools, and personalised prevention messaging, particularly around privacy and potential stigma. Practical segments will show how to communicate population-level risk information in ways that are meaningful and empowering for families and policymakers. Finally, the session will highlight opportunities for collaboration across countries and regions, enabling shared learning and harmonised methodologies that advance global understanding of pediatric allergy trends while supporting locally tailored solutions. Through these perspectives, attendees will gain a toolkit for moving from data to action, ensuring that research on allergy patterns ultimately reduces disease burden and improves everyday life for children and their families.